Induction of p28 cleavage and procaspase-3 (pro-CPP32) processing during apoptosis in vivo. (A) Cell extracts were obtained from KB cells that had either been infected for 60 h with adenovirus pm1716/2072 lacking expression of E1B 19K or had been mock infected (+ or − Apoptosis, respectively). After 12% SDS-PAGE and transfer to nitrocellulose, blots were incubated with affinity-purified chicken antibody against p28 amino acids 165–246 (α p28-C) or p28 amino acids 122–164 (α p28-M) and were developed with secondary antibody conjugated either to HRP and visualized by electrochemiluminescence (Amersham Intl., Arlington Heights, IL) (α p28-M) or to alkaline phosphatase and visualized with NBT/BCIP (Boehringer Mannheim Biochemicals, Indianapolis, IN) (α p28-C), according to the manufacturer's instructions. Bands corresponding to p28 are indicated. Arrows labeled a and b denote products whose sizes are consistent with cleavage of p28 at the sites designated a and b in the schematic. (B) KB cells expressing neomycin resistance either alone (minus Bcl-2, lanes 6–10) or together with Bcl-2 (plus Bcl-2, lanes 1–5) were infected with adenovirus pm1716/2072 lacking expression of E1B 19K and cell extracts prepared at 0, 24, 36, 48, and 60 h postinfection (p.i.; lanes 1 and 6, 2 and 7, 3 and 8, 4 and 9, and 5 and 10, respectively). Aliquots (15 μg protein) were subjected to 12% SDS-PAGE, transferred to nitrocellulose, and blots were probed with antibody against p28-M or against the 17-kD subunit of CPP32 (Boulakia et al., 1996), and the products were developed as described in A. The positions of p28 and the cleavage products a and b are indicated in the upper panels. The arrow denotes a cross-reacting product whose appearance is variable (e.g., it did not appear in A). The positions of full length pro-CPP32 and the processed 17-kD subunit (p17) and putative 29-kD processing intermediate (asterisk) are indicated in the lower panels.